The IJTLD
The IJTLD is the leading peer-reviewed journal dedicated to lung health worldwide.
We welcome submissions on basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
Public Health Action
Public Health Action aims to disseminate the latest operational research on health systems, public health and disease control.
We have recently expanded the scope of PHA to provide coverage of relevant areas of the UN's Sustainable Development Goals (SDGs).
IJTLD Open
Launched in January 2024, IJTLD Open is The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD.
We welcome submissions on the development of diagnostics and treatments for the prevention, management and control of respiratory diseases.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Tackling TB and COVID-19: US leadership is needed on global health, now more than ever
In the lead up to World TB Day, an article in PHA calls for increased funding and renewed leadership to coordinate the global fight against TB. A relatively small investment in TB control has the potential to transform TB care, saving millions of lives and trillions of dollars in the global economy.
Impact of influenza A co-infection with COVID-19
This study reports on the rate of co-infection with influenza A in a cohort of COVID-19 patients and its impact on the clinical course and outcome.
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
The authors investigate the potential impact of COVID-19 on people with RR-TB.
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
The authors highlight the use of community testing as a means of addressing the impact of COVID-19 on TB diagnosis.